Mitochondrial reactive oxygen species generation triggers inflammatory response and tissue injury associated with hepatic ischemia-reperfusion: Therapeutic potential of mitochondrially targeted antioxidants. by Mukhopadhyay, P. et al.
  
Serveur Académique Lausannois SERVAL serval.unil.ch 
Author Manuscript 
Faculty of Biology and Medicine Publication 
This paper has been peer-reviewed but dos not include the final publisher 
proof-corrections or journal pagination. 
Published in final edited form as:  
 
In the absence of a copyright statement, users should assume that standard copyright protection applies, unless the article contains 
an explicit statement to the contrary. In case of doubt, contact the journal publisher to verify the copyright status of an article. 
 
Title: Mitochondrial reactive oxygen species generation triggers 
inflammatory response and tissue injury associated with hepatic 
ischemia-reperfusion: therapeutic potential of mitochondrially 
targeted antioxidants. 
Authors: Mukhopadhyay P, Horváth B, Zsengellėr Z, Bátkai S, Cao Z, 
Kechrid M, Holovac E, Erdėlyi K, Tanchian G, Liaudet L, Stillman IE, 
Joseph J, Kalyanaraman B, Pacher P 
Journal: Free radical biology &amp; medicine 
Year: 2012 Sep 1 
Volume: 53 
Issue: 5 
Pages: 1123-38 
DOI: 10.1016/j.freeradbiomed.2012.05.036 
 
Mitochondrial reactive oxygen species generation triggers
inflammatory response and tissue injury associated with hepatic
ischemia-reperfusion: therapeutic potential of mitochondrially-
targeted antioxidants
Partha Mukhopadhyay1,*, Bėla Horváth1,*, Zsuzsanna Zsengellėr3,*, Sándor Bátkai1,*,
Zongxian Cao1, Malek Kechrid1, Eileen Holovac1, Katalin Erdėlyi1, Galin Tanchian1, Lucas
Liaudet4, Isaac E. Stillman3, Joy Joseph2, Balaraman Kalyanaraman2, and Pál Pacher1
1Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, National
Institutes of Health, Bethesda, Maryland, USA 2Free Radical Research Center, Medical College
of Wisconsin, Milwaukee, Wisconsin 53226 3Department of Pathology, Beth Israel Deaconess
Medical Center, and Harvard Medical School, Boston, Massachusetts 02215, USA 4Department
of Intensive Care Medicine, University Hospital Center and Faculty of Biology and Medicine, 1011
Lausanne, Switzerland
Abstract
Mitochondrial reactive oxygen species generation has been implicated in the pathophysiology of
ischemia-reperfusion (I/R) injury, however its exact role and its spatial-temporal relationship with
inflammation are elusive. Herein we explored the spatial-temporal relationship of oxidative/
nitrative stress and inflammatory response during the course of hepatic I/R and the possible
therapeutic potential of mitochondrial-targeted antioxidants, using a mouse model of segmental
hepatic ischemia-reperfusion injury. Hepatic I/R was characterized by early (at 2 hours of
reperfusion) mitochondrial injury, decreased complex I activity, increased oxidant generation in
the liver or liver mitochondria, and profound hepatocellular injury/dysfunction with acute pro-
inflammatory response (TNF-α, MIP-1αCCL3, MIP-2/CXCL2) without inflammatory cell
infiltration, followed by marked neutrophil infiltration and more pronounced secondary wave of
oxidative/nitrative stress in the liver (starting from 6 hours of reperfusion and peaking at 24
hours). Mitochondrially-targeted antioxidants, MitoQ or Mito-CP, dose-dependently attenuated I/
R-induced liver dysfunction, the early and delayed oxidative and nitrative stress response (HNE/
carbonyl adducts, malondialdehyde, 8-OHdG, and 3-nitrotyrosine formation), mitochondrial and
histopathological injury/dysfunction, as well as delayed inflammatory cell infiltration and cell
death.
Mitochondrially generated oxidants play a central role in triggering the deleterious cascade of
events associated with hepatic I/R, which may be targeted by novel antioxidants for therapeutic
advantage.
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Introduction
Ischemia-reperfusion (I/R) inflicted by transient ischemia followed by reperfusion is a
pivotal mechanism of organ injury during various pathological conditions (e.g. myocardial
infarction, stroke, vascular surgeries, circulatory shock, and organ transplantation). Surgical
interventions in the liver, transplantation, inflammatory and vascular diseases, circulatory
shock or various toxic insults may lead to hepatic I/R injury resulting in organ dysfunction
or failure, depending on the duration of the insult [1–3]. Early generation of reactive oxygen
(e.g. superoxide and hydrogen peroxide) and nitrogen (e.g. peroxynitrite) species (ROS/
RNS) during reperfusion is considered playing a pivotal role in initiating a chain of
deleterious cellular responses leading to inflammation and cell death, which eventually
culminate in target organ dysfunction/failure [3–11]. Mitochondrial proteins are particularly
sensitive targets for ROS/RNS [12], and their inactivation by oxidants may contribute to
dysfunction and injury during hepatic [13] and other forms of liver injury [14].
Dysfunctional mitochondria may also generate significant amount of ROS during hepatic I/
R in addition to activated xanthine oxidoreductases, NADPH oxidases in various key cell
types of the liver (e.g. hepatocytes, endothelial, Kupffer, and infiltrating immune cells) [15–
17].
Despite numerous reports on the role of oxidative stress and mitochondrial dysfunction in
hepatic I/R injury, and on the beneficial effects of global antioxidants, the exact role of
mitochondrial ROS generation in liver I/R injury is still largely elusive. Furthermore, there
is very limited information on the spatial-temporal relationship of the oxidative and nitrative
stress and inflammatory response during hepatic I/R, and on the main cellular sources/
targets of ROS/RNS generation. In this study, we used a well-established mouse model of in
vivo segmental hepatic I/R injury [13, 18–20] and two well-characterized mitochondrially-
targeted small-molecule antioxidants, MitoQ and Mito-CP [21–24], to investigate the role of
oxidative stress and mitochondrial oxidant generation during the course of hepatic I/R.
Materials and methods
Hepatic ischemia-reperfusion
The study has been approved by the Institutional Animal Care and Use Committees of
NIAAA, and has been carried out in line with the National Institutes of Health (NIH)
guidelines for the care and use of laboratory animals. Male C57BL/6J mice (25–30g;
Jackson Laboratories, Bar Harbor, ME) were anesthetized with pentobarbital sodium (65
mg/kg i.p.). In our study, the model of segmental (70%) hepatic ischemia-reperfusion has
been used, as described [13, 18–20, 25, 26]. Two mitochondrially-targeted antioxidants,
which most likely inhibit lipid peroxidation and also quench peroxynitrite, Mito-Q and
Mito-CP were synthesized as described [21, 27]. MitoQ and Mito-CP were stored in ethanol
at 50 mg/ml, further diluted in saline and administered at 0.3–3 mg/kg or as described, i.p.
once, 1.5 hour before I/R. Mito-Q and Mito-CP at 3 mg/kg or vehicle were also given right
after the ischemia at the moment of reperfusion (post I (R 0h)) or 3h after ischemia (post I
(R 3h)), as indicated in the text. At the experimental end points at 2, 6 and 24 hours
following ischemia (I/R 2, 6 and 24h), blood was collected and liver samples were removed
and snap-frozen in liquid nitrogen for determining biochemical parameters or fixed in 4%
buffered formalin for histopathological evaluation.
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Serum AST and ALT levels
The activities of aspartate amino-transferase (AST) and alanine amino-transferase (ALT),
indicators of liver cellular damage, were measured in serum samples using a clinical
chemistry analyzer system (VetTest 8008, IDEXX laboratories, Westbrook, ME) [13, 19].
Histological examination of liver sections
Liver samples were fixed in 4% buffered formalin. After embedding and cutting 5 μm
slices, all sections were stained with hematoxylin/eosin (HE). Myeloperoxidase staining of
neutrophils was done by using anti-myeloperoxidase antibody according to the
manufacturer’s protocol (Biocare Medical, Concord, CA), and samples were counter-stained
with nuclear fast red as described [19]. Liver sections were also stained for malondialdehyde
(Genox Corporation, Baltimore, MD), nitrotyrosine (Cayman Chemical, Ann Arbor, MI)
and 8-hydroxy-2′-deoxyguanosine (8-OHdG) (Genox Corporation, Baltimore, MD)
according to the manufacturer’s protocol and/or as described [20, 28]. Both
malondialdehyde and nitrotyrosine stained sections were counter stained with nuclear fast
red. The specific staining was visualized and images were acquired using microscope IX-81
with 20X, 40X and 100x objectives (Olympus, Center Valley, PA) [20, 28]. Histological
evaluation was performed in a blinded manner.
Electron Microscopy
Livers of anesthetized animals were perfusion fixed with 1.25 % glutaraldehyde in 0.1 M
cacodylate buffer. Livers were harvested and processed in standard fashion (Epon
embedded) for transmission electron microscopy using a JEOL 1011 Electron Microscope as
described [28].
Real-Time PCR Analyses of mRNA
Total RNA was isolated from liver homogenate using TRIzol reagents (Invitrogen, Carlsbad,
CA) according to manufacturer’s instructions. The isolated RNA was treated with RNase-
free DNase (Ambion, Austin, TX) to remove traces of genomic DNA contamination. One
microgram of total RNA was reverse-transcribed to cDNA using the SuperScript II
(Invitrogen, Carlsbad, CA). The target gene expression was quantified with Power SYBER
Green PCR Master Mix using an ABI HT7900 real-time PCR instrument (Applied
Biosystems, Foster City, CA). Each amplified sample in all wells was analyzed for
homogeneity using dissociation curve analysis. Relative quantification was calculated using
the comparative CT method.
All primers used were previously described [20, 26, 29, 30]:
TNF-α, 5′-AAGCCTGTAGCCCACGTCGTA-3′ and 5′-
AGGTACAACCCATCGGCTGG-3′; MIP-1α, 5′-TGCCCTTGCTGTTCTTCTCTG-3′ and
5′-CAACGATGAATTGGCGTGG-3′; MIP-2, 5′-AGTGAACTGCGCTGTCAATGC-3′
and 5′-AGGCAAACTTTTTGACCGCC-3′; gp91Phox (NOX2), 5′-
GACCATTGCAAGTGAACACCC-3′ and 5′-AAATGAAGTGGACTCCACGCG-3′; and
actin, 5′-TGCACCACCAACTGCTTAG-3′ and 5′-GGATGCAGGGATGATGTTC-3′.
Immunoblot analyses
Liver tissues were homogenized in mammalian tissue protein extraction reagent (Pierce,
Rockford, IL, USA) supplemented with protease and phosphatase inhibitors (Roche
Diagnostics) Blots were probed with gp91phox (BioLegend Inc, San Diego, CA) used at
1:1000 dilution and incubated overnight at 4 C. After subsequent washing with PBS–Tween,
the membranes were probed with appropriate secondary antibodies conjugated with HRP
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(Pierce, Rockford, IL) and incubated 1h at room temperature. Then the membranes were
developed using a SuperSignal–West Pico substrate chemiluminescence detection kit
(Pierce, Rockford, IL). To confirm uniform loading, membranes were stripped and re-
probed with β-actin (Chemicon, Ramona, CA, USA).
Isolation of Mitochondrial fraction
Mitochondria were isolated from the livers of mice treated with vehicle, or Mito-CP/MitoQ
with or without exposure to I/R using tissue mitochondrial isolation kit (Pierce
Biotechnology, Rockford, IL) as decribed [20].
Determination of mitochondrial complex activity
Microplate assay kits (MitoSciences, Inc., Eugene, OR, USA) were used to determine the
activity of Mitochondrial complex I, complex II and complex IV according to the
manufacturer’s instructions. The complex enzymes were immunocaptured within the wells
of the microplate and activities were determined colorimetrically. Complex activities were
expressed as percentage activity compared to the liver samples of the vehicle-treated mice as
described [20].
Hepatic and/or mitochondrial 4-hydroxynonenal (HNE) content and protein oxidation
Lipid peroxides are unstable indicators of oxidative stress in cells that decompose to form
more complex and reactive compounds such as 4-hydroxynonenal (HNE), which has been
shown to be capable of binding to proteins and forming stable HNE adducts. HNE adducts
in the hepatic tissues or from mitochondrial fractions were determined using a kit (Cell
Biolabs, San Diego, CA). In brief, BSA or hepatic tissue extracts (10 μg/mL) were adsorbed
onto a 96-well plate. HNE adducts present in the sample or standard were probed with anti-
HNE antibody, followed by an HRP conjugated secondary antibody. The HNE-protein
adducts content in an unknown sample was determined by comparing with a standard curve.
The protein oxidation was also determined in isolated mitochondrial fractions by OxyBlot
Protein Detection Kit from EMD Millipore (Billerica, MA) according to manufacturer
instructions. This method is based on the immunoblot detection of carbonyl groups
introduced into proteins by oxidative reactions with ozone or oxides of nitrogen or by metal
catalyzed oxidation.
Mitochondria for oxyblot analyses were purified by magnetic beads method (Mitochondria
Isolation Kit, Miltenyi Biotec, Auburn, CA) as described earlier [31]. The isolation of
mitochondria was carried out according to manufacturer’s instruction. Briefly, fresh
harvested liver was homogenized by gentleMACS dissociator (Miltenyi Biotec, Auburn,
CA). To magnetically label mitochondria, the homogenate was incubated with 50 μl of
monoclonal anti-TOM22-conjugated microBeads for 1 hour at 4°C. Then, the suspension of
labeled mitochondria was loaded onto a pre-equilibrated MACS Column (Miltenyi Biotec,
Auburn, CA), previously placed in the magnetic field of a MACS Separator (Miltenyi
Biotec, Auburn, CA). Due to the magnetic field generated by the MACS Separator, labeled-
mitochondria were retained into the column. The column was washed three times with 3 ml
suspension buffer provided with the kit. Subsequently, the column was removed from the
magnetic field and the retained mitochondria were eluted in 1 ml suspension buffer. The
mitochondrial lysates were prepared in RIPA buffer and the purity of mitochondrial fraction
was analyzed by western blot with cytochrome c oxidase (COX IV) antibody (Abcam,
Cambridge, MA).
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Hepatic protein carbonyl content
Protein oxidation is defined as the covalent modification of the proteins induced by reactive
oxygen species. Oxidative modification of proteins can be induced by wide array of pro-
oxidant stimulus, and elevated levels were demonstrated in several pathological conditions.
An ELISA-based assay (Cell Biolabs Inc., San Diego, CA) was used to measure the protein
carbonyl levels in isolated liver mitochondrial fractions. In brief, BSA standards or protein
samples were adsorbed on to 96-well plates for 2 h at 37°C. The protein carbonyls present in
the samples or standards were derivatized to DNP hydrazones with dinitrophenylhydrazine
(DNPH) and incubated with anti-DNP antibody, followed with HRP conjugated secondary
antibody. Then the absorbance was measured at 450 nm using a plate reader (Spectramax
Plus, Molecular Device, Sunnyvale, CA) as described [32, 33]..
Hepatic 3-nitrotyrosine (NT) content
NT content was measured by the NT ELISA kit from Hycult Biotechnology (Cell Sciences,
Canton, MA) from tissue homogenates as described [20, 33]. Levels were presented as fold
changes compared to vehicle-treated control sample.
Hepatic DNA fragmentation and poly (ADP-ribose) polymerase (PARP) activity
The quantitative determinations of cytoplasmic histone-associated-DNA-fragmentation
(mono and oligonucleosomes) due to cell death in liver homogenizates were measured using
ELISA kit (Roche Diagnostics GmbH, Indianapolis, IN)[34]. Hepatic PARP activity was
assayed using a colorimetric kit according to the manufacturer’s protocol (Trevigen,
Gaithersburg, MD) as described [20].
Analysis of data
Results are expressed as means ± SEM. Statistical significance among groups was
determined by one-way ANOVA followed by Newman-Keuls post hoc analysis using
GraphPad Prism 5 software (San Diego, CA). Probability values of P<0.05 were considered
significant.
Results
Mitochondrially-targeted antioxidants attenuate markers of hepatic I/R injury (ALT, AST)
and histological damage
After 1 hour of ischemia and a subsequent 2 or 6 hours of reperfusion (I/R 2 h or I/R 6h), a
dramatic increase in the serum transaminase enzyme activities (AST and ALT; markers of
hepatocellular damage/necrosis) were observed in vehicle-treated C57BL/6J mice (peaking
at 6h of reperfusion), as compared with sham-operated controls (Figure 1B–D). At 24 hours
of reperfusion (I/R 24h) the transaminase activities declined compared I/R 6h, but were still
elevated compared to sham-operated controls (Figure 1D). Pretreatment with MitoQ or
Mito-CP (Figure 1A) (0.3–3 mg/kg i.p.) 1.5 hours before the induction of the ischemia dose-
dependently attenuated the serum transaminase elevations at 6 hours of reperfusion
compared to vehicle (Figure 1B–C). MitoQ or Mito-CP (3 mg/kg i.p.) 1.5 hours before the
induction of the ischemia significantly attenuated the serum transaminase elevations at 2, 6,
and 24 hours of reperfusion compared to vehicle (Figure 1D). MitoQ and Mito-CP (3 mg/kg
i.p.) were also effective in attenuating the I/R-induced peak ALT/AST elevations at 6 h of
reperfusion when administered right after the 1 h ischemic period before the start of the
reperfusion (Figure 2A; post I (R 0h)), however they lost their protective effects on liver
dysfunction when administered at 3 hours of reperfusion (Figure 2B; post I (R 3h)).
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We hypothesized that the mitochondrial dysfunction/ROS generation triggers the deleterious
cascade of events during I/R (e.g. secondary inflammatory response and ROS/RNS
generation, etc.), therefore we studied mitochondrial structure early at 2 h of reperfusion.
The electron microscopy of the non-ischemic control livers of mice undergoing sham
surgery (sham) revealed normal hepatic tissue with good preservation of hepatocytes and
lining cells of sinusoidal venules, as well as normal mitochondrial structure (Figure 3A, left
panels), which were similar in sham mice treated with MitoQ or Mito-CP (3 mg/kg i.p.)
(Figure 3A middle and right panels).
Post-ischemic liver tissue at 2 hours of reperfusion (I/R 2h) exhibited marked disintegration
of ultrastructure (e.g., swelling of mitochondria, vacuolization, nuclear and cytoplasmic
degeneration) in most hepatocytes (Figure 3B, left panels). The majority of mitochondria
exhibited alterations in size, shape, and matrix. In some mitochondria the matrix totally
disappeared and only the outer membrane remained, while in others, the cristae appeared
disorganized because of edema in the matrix, and many of them lost the spherical or
ellipsoid shape (Figure 3B, left panels). Mito-CP and MitoQ pretreatment (3 mg/kg i.p.)
markedly attenuated the morphological and mitochondrial injury induced by 1 h of ischemia
followed by 2 hours of reperfusion (I/R 2h) to a similar extent (Figure 3B, middle and right
panels).
Representative liver sections of sham mice, mice exposed to 1 hour of ischemia followed by
2, 6 and 24 hours of reperfusion (I/R) with vehicle or Mito-CP/MitoQ pretreatment were
stained with hematoxylin and eosin (Figure 4). The I/R-induced marked coagulation
necrosis was histologically clearly separated by 6 and 24h of I/R (lighter areas, with marked
inflammatory cell infiltration at 24 hours of reperfusion), which was dramatically reduced
and became more focal in Mito-CP/MitoQ treated mice (Figure 4). Mito-CP/MitoQ
treatment alone or vehicle had no effect on the liver histopathology. Figure 4 depicts 200×
magnifications.
Mitochondrially-targeted antioxidants attenuate the I/R-induced oxidative and nitrative
stress, and mitochondrial dysfunction in the liver
The rate of hepatic lipid peroxidation (HNE; Figure 5A) was negligible in sham-operated
mouse liver as indicated by the low levels of HNE adducts. Hepatic HNE adducts time-
dependently increased at 2, 6 and 24 hours of reperfusion, and were markedly attenuated by
mitochondrial antioxidants (Figure 5A). Consistently with early mitochondrial injury
(Figure 3) and ROS/RNS formation (Figure 5A–D), the level of hepatic and mitochondrial
HNE adducts (Figure 5A and B) and oxidized proteins (protein carbonyl adducts; Figure 5C
and D) were elevated at 2 h of reperfusion. Marked attenuation of mitochondrial complex I
activity was also observed at 2h of reperfusion, without significant changes in complex II
and IV activities (Figure 5E).
Mitochondrial antioxidants almost completely prevented the I/R-induced early elevation of
HNE and/or protein oxidation in the mitochondria (Figure 5A–D), as well as attenuated the
impaired complex I activity measured from isolated liver mitochondria (Figure 5E, left
panel). These data indicate that mitochondria represent the primary source of ROS
generation during early reperfusion injury and Mito-CP/MitoQ is able to selectively target
ROS in these organelles.
24 hours of I/R also induced marked increases in liver malondialdehyde formation (another
index of lipid peroxidation; brown staining), which was predominantly localized to
endothelial cells, perivascular hepatocytes, and infiltrating (or attached to the endothelium)
inflammatory cells (Figure 6A, second pair of images from the left). Mitochondrial
antioxidants markedly attenuated the I/R-induced malondialdehyde formation in the liver
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(Figure 6A, 2 pairs of images from the right). Similar pattern but weaker staining (without
infiltrating immune cells) was observed at earlier time points (I/R 2 and 6h; data not shown).
Minimal staining could be seen in the livers of control mice exposed to sham surgery
(Figure 6A, left panels).
24 hours of I/R was also associated with increased 8-OHdG formation (a marker of
oxidative DNA injury; strong dark blue nuclear staining) in endothelial cells, perivascular
hepatocytes and infiltrating inflammatory cells (Figure 6B, second pair of images from the
left). Mitochondrial antioxidants markedly attenuated the I/R-induced 8-OHdG formation in
the liver (Figure 6B, 2 pairs of images from the right). Minimal nuclear 8-OHdG staining
could be seen in the livers of control mice exposed to sham surgery (Figure 6B, left panels).
The upper row of images (Figures 6A and B) depicts 400× magnification, the lower 1000×.
Consistently with previous studies [16, 20] from 6 h of reperfusion there was an increased
expression (mRNA and/or protein) of ROS generating NADPH oxidase isoform NOX2/
gp91phox in the liver, coinciding with the inflammatory cell infiltration; which were also
attenuated by Mito-CP/MitoQ pretreatments (Figure 7A,B). In contrast, when Mito-CP/
MitoQ were administered 3 hours after the ischemia they were not able to attenuate the I/R-
induced NOX2 protein expression determined at 24 hours of reperfusion (Figure 7C).
I/R was also associated with time-dependent marked increases of hepatic and/or
mitochondrial 3-nitrotyrosine formation (Figures 8A–C, and 9), a marker of peroxynitrite
formation and more broadly nitrative stress [3]), showing similar cellular localization to
malondialdehyde and 8-OHdG in endothelial cells, perivascular hepatocytes, and infiltrating
(or attached to the endothelium) inflammatory cells (Figures 6, 8 and 9). Mito-CP/MitoQ
markedly attenuated the hepatic/mitochondrial nitrative damage (Figures 8A–C and 9).
Figure 8C depicts 400× magnification, Figure 9 depicts 1000×.
Mitochondrially-targeted antioxidants attenuate the I/R-induced acute and delayed
inflammatory responses
I/R induced time-dependent changes in the mRNA expression of the pro-inflammatory
cytokine tumor necrosis factor α (TNF-α), chemokines macrophage inflammatory proteins
1α and 2 (MIP-1α/CCL3 and MIP2/CXCL2), intercellular adhesion molecule 1 (ICAM-1/
CD54) (Figures 10, and 11A), and hepatic myeloperoxidase activity and staining (an
indicator of leukocyte infiltration; Figure 11B-D). The I/R-induced acute hepatic pro-
inflammatory response (TNF-α, MIP-1α/2, ICAM-1; most likely orchestrated by activated
Kupffer and endothelial cells [20, 35] peaked at 2 hours of reperfusion and was largely
declined thereafter by 24 hours of reperfusion (Figures 10 and 11A). In contrast, the delayed
inflammatory cell (predominantly myeloperoxidase positive neutrophil (brown staining))
infiltration started only from 6 hours of reperfusion peaking at 24 hours of reperfusion
(Figures 11C and D). These changes in inflammatory responses were largely attenuated by
pre-treatment with Mito-CP/MitoQ (3 mg/kg i.p., Figures 10, and 11A–D). Figure 11C
depicts 200× magnification, Figure 11D depicts 400×.
Mitochondrially-targeted antioxidants attenuate the I/R-induced cell death
I/R markedly increased the poly (ADP-ribose) polymerase-dependent (mostly necrotic) and
apoptotic (DNA fragmentation, caspase 3/7activity) cell death (Figure 12A–C) in the liver,
which were prevented by Mito-CP/MitoQ. Notably, while PARP activity was already
increased early following reperfusion (Figure 12A), the apoptotic cell death was evident
mainly at 24 h of I/R only (Figure 12B and C).
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Discussion
In this study we explored the therapeutic potential of mitochondrially-targeted antioxidants
in a well-established mouse model of segmental hepatic ischemia-reperfusion (I/R) injury
[13, 18–20, 26]. Previous in vitro, ex vivo, and in vivo studies using this and other models of
hepatic I/R have implicated an important role of oxidative/nitrative stress, mitochondrial
dysfunction and inflammation in hepatic I/R injury, and demonstrated beneficial effects of
various global antioxidants [5, 7, 13, 15, 17, 36]. However, the exact role of mitochondrial
ROS generation during liver I/R injury is still largely elusive, likewise the spatial-temporal
relationship of the oxidative/nitrative stress and inflammatory cell infiltration. We
hypothesized that the I/R-induced mitochondrial oxidative stress results in mitochondrial
injury and dysfunction, which may trigger a cascade of deleterious cellular consequences
continuously fueling oxidative/nitrative stress, endothelial and hepatocyte cell demise, local
inflammation, eventually culminating in liver dysfunction/failure. To test this hypothesis, we
administered membrane-permeable small molecule antioxidants that target mitochondria 1.5
hr before I/R challenge and observed marked improvements in each of these pathogenic
events including, most importantly, hepatocellular damage. These findings indicate that
mitochondrial ROS is a crucial mediator of hepatic I/R injury, which can be selectively
targeted by novel antioxidants for therapeutic gain.
The early damaging effect of I/R is caused by the generation of superoxide and other forms
of ROS during reperfusion which may involve activation of xathine oxidoreductases [15, 37,
38], impairment of the activities of the enzymes of the mitochondrial respiratory chain,
mitochondrial dysfunction, allowing more ROS to leak out of the respiratory chain [6, 13,
20]. Superoxide may also readily react with nitric oxide (NO) during early hepatic
reperfusion (the latter can be derived from nitric oxide synthases, most likely iNOS [39]) via
a diffusion limited reaction to form a more potent oxidant peroxynitrite [40], further
impairing mitochondrial [12] and cellular functions and increasing ROS generation [3, 4].
Hepatic I/R also attenuates endothelial NO synthase activity in sinusoidal endothelial cells
during I/R leading to endothelial dysfunction, favoring sinusoidal vasoconstriction. The
initial oxidant-induced injury also leads to the activation of endothelial cells and the resident
macrophages of the liver, the Kupffer cells [2], which together orchestrate the acute and
delayed pro-inflammatory response leading to attraction of neutrophils and other
inflammatory cells into the damaged tissue upon reperfusion [2, 20]. These inflammatory
cells further release oxidants and proteolytic enzymes enhancing intracellular oxidative/
nitrative stress and mitochondrial dysfunction in hepatocytes, thereby promoting apoptotic
and/or necrotic, or other forms of cell demise [6, 9, 41].
Increased oxidative/nitrative stress was one of the earliest features we observed during the
initial phase of hepatic I/R (I/R 2h) both in the liver, as well as in the isolated liver
mitochondria. The above mentioned changes were also accompanied by structural
mitochondrial injury in the liver, decreased mitochondrial complex I activity, and
hepatocellular necrosis. The early mitochondrial and hepatocellular injury and dysfunction
were coupled with an acute pro-inflammatory cytokine/chemokine response (originating
from activated Kupffer and endothelial cells) without significant inflammatory cell
infiltration. The above mentioned pathological changes were followed by profound delayed
neutrophil infiltration and a secondary wave of ROS/RNS generation from 6 hours
following ischemia (IR 6 h), peaking at 24 hours of reperfusion (I/R 24h). The later
response, consistently with other reports [20], most likely involved the phagocyte NAD(P)H
oxidase isoform gp91phox/NOX2 [16], increased iNOS and cyclooxygenase 2
expression[20], and coincided with enhanced leukocyte infiltration in the injured livers. The
I/R-induced ROS/RNS generation may also induce expression of adhesion molecules
through the activation of NF-κB[18, 20]. Indeed, we found increased expression of adhesion
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molecule ICAM-1 in the liver exposed to I/R. This, coupled with the pro-inflammatory
cytokines/chemokines released by activated Kupffer and endothelial cells, and possibly
certain subpopulations of T cells, may facilitate migration, adhesion and activation of
neutrophils to the site of injury, which may further amplify oxidative and nitrative stress,
and these processes are interrelated leading to a concerted activation of various
mitochondrial and other (e.g. PARP-1-dependent) cell death pathways.
A single dose of mitochondrially-targeted antioxidants, MitoQ/Mito-CP, not only attenuated
the I/R-induced liver dysfunction, mitochondrial and hepatic early and delayed oxidative
and nitrative stress (HNE/carbonyl adducts, malondialdehyde, 8-OHdG, and nitrotyrosine),
mitochondrial and histopathological injury/dysfunction, but also blunted the early and the
secondary wave of pro-inflammatory responses and associated cell death. Our results are
also in agreement with a recent study demonstrating protective effects of MitoQ against
alcohol-induced liver injury, where MitoQ successfully attenuated the alcohol-induced
hepatic mitochondrial complex I dysfunction and associated oxidative/nitrative damage [14].
Even though the exact mechanisms of the direct protective effects of MitoQ/Mito-CP are not
known, our study supports the view that these antioxidants can attenuate mitochondrial
dysfunction and ROS/RNS generation in vivo under pathological conditions, most likely by
attenuating lipid peroxidation and/or by quenching peroxynitrite. The most likely primary
cellular targets of the protective effects of these compounds against liver I/R injury are the
hepatocytes and endothelial cells; however in light of the emerging view that mitochondrial
ROS/RNS formation may directly or indirectly control expression of NAD(P)H oxidases
[42] and other key processes in various cell types, a direct effect of MitoQ/Mito-CP on early
Kupffer cell activation cannot be excluded either. On the other hand, compelling evidence
suggests that various molecules released from necrotic hepatocytes during early hepatic I/R
(e.g. high mobility group 1 proteins (HMGB1) and DNA fragments), as well as lipid
peroxidation products such as hydroxynonenal (HNE), are key triggers of Kupffer cells
activation via toll like receptors (TLRs) [2, 43, 44]. Thus, attenuation of early mitochondrial
dysfunction, oxidative/nitrative stress, and subsequent necrotic cell death in hepatocytes and
endothelial cells during early I/R can also lead indirectly to attenuation of the acute pro-
inflammatory response orchestrated by activated Kupffer cells and consequent delayed
inflammatory cell infiltration. Figure 13 summarizes the key pathological processes during
hepatic I/R injury.
Collectively, these observations strongly indicate that early mitochondrial ROS generation
triggers the deleterious cascade of inflammation and tissue injury associated with hepatic I/R
(Figure 13). Thus, mitochondrially-targeted antioxidants such as MitoQ, which appear to be
safe in humans and are recently being evaluated for potential therapeutic use [45, 46] (see
ClinicalTrials.gov), may represent a promising approach to attenuate the I/R-inflicted liver
and most likely other forms of tissue injury, and inflammation.
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Highlights
Ischemia-reperfusion (I/R) injury is a pivotal mechanism of organ damage/
dysfunction
The exact role and time of mitochondrial oxidants generation in liver I/R is elusive
Mitochondrial oxidants generation triggers I/R-induced liver inflammation and
injury
Mitochondrial antioxidants (MTAs) prevent the I/R-induced oxidative/nitrative
injury
MTAs prevent the I/R-induced acute/delayed inflammatory response and cell death
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Figure 1. MitoQ and Mito-CP pretreatment dose-dependently attenuates hepatic I/R injury
Panel A: Chemical structures of MitoQ and Mito-CP.
Panels B and C: Serum transaminases ALT and AST levels in sham-operated mice treated
with vehicle or in mice exposed to 1 h of hepatic ischemia followed by 6 h of reperfusion (I/
R 6h) pretreated with vehicle, MitoQ or Mito-CP (0.3, 1 and 3 mg/kg i.p., n=6–21/group).
Panel D: Serum ALT and AST levels in sham operated mice treated with vehicle, MitoQ or
Mito-CP (n=6–21/group) or in mice exposed to 1 h of hepatic ischemia followed by 2, 6 and
24 hours of reperfusion (I/R 2h, 6 h and 24h) pretreated with vehicle or MitoQ/Mito-CP (3
mg/kg i.p.). The peak damaged occurs at I/R 6h, and MitoQ/Mito-CP is able to attenuate the
inflicted injury at any point investigated. *P<0.05 sham control vs. I/R; #P<0.05 I/R vs.
corresponding I/R+ MitoQ/Mito-CP.
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Figure 2. MitoQ and Mito-CP treatment after ischemia attenuates hepatic I/R injury
Panels A and B: Serum transaminases ALT and AST levels in sham-operated mice or in
mice exposed to 1 h of hepatic ischemia followed by 6 h of reperfusion (I/R 6h) treated with
vehicle or MitoQ/Mito-CP (3 mg/kg i.p., n=6–10/group) right after the ischemia before the
reperfusion (post I (R 0h)) or 3 hours following the ischemia (post I (R 3h)), respectively.
*P<0.05 sham control vs. I/R; #P<0.05 I/R vs. corresponding I/R+ MitoQ/Mito-CP.
Notably, MitoQ/Mito-CP are able to attenuate the inflicted injury only when administered
right after the ischemia, but not 3 hours after.
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Figure 3. MitoQ and Mito-CP treatment attenuates I/R injury-induced early mitochondrial
injury
Panel A: Representative transmission electron micrographs of the non-ischemic control
livers of mice undergoing sham surgery (sham) treated with vehicle reveal normal hepatic
tissue with good preservation of hepatocytes and lining cells of sinusoidal venules, as well
as normal mitochondrial structure, which are not affected by treatments with MitoQ/Mito-
CP (3 mg/kg i.p.). Upper images depict 12,000× and lower 30,000× magnification.
Panel B: Post-ischemic liver tissue at 2 hours of reperfusion (I/R 2h) exhibit marked
disintegration of ultrastructure (e.g., swelling of mitochondria, vacuolization, nuclear and
cytoplasmic degeneration) in most hepatocytes. In some mitochondria the matrix totally
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disappears and only the outer membrane remains, while in others, the cristae are
disorganized because of edema in the matrix (left images). Mito-CP/MitoQ pretreatment (3
mg/kg i.p.) markedly attenuates the morphological and mitochondrial injury induced by 1 h
of ischemia followed by 2 hours of reperfusion (I/R 2h) to a similar extent (middle and right
panels). Upper images depict 12,000× and lower 30,000× magnification. A similar
histological profile was seen in three to five livers/group.
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Figure 4. MitoQ and Mito-CP treatment attenuates histological damage at 2, 6 and 24h of
reperfusion following 1 hour of ischemia
Hematoxylin and eosin staining of representative liver sections of sham mice treated with
vehicle (sham), and mice exposed to 1 hour of ischemia followed by 2, 6 or 24h of
reperfusion treated with vehicle or Mito-CP/MitoQ (3 mg/kg i.p.). I/R inflicts marked
coagulation necrosis in the liver (lighter staining at 6 and 24 h of reperfusion), which is
markedly attenuated by MitoQ/Mito-CP pretreatment. MitoQ/Mito-CP has no effect in
control mice exposed to sham surgery. Figure 4 depicts 200x magnification. A similar
histological profile was seen in three to five livers/group.
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Figure 5. MitoQ and Mito-CP treatment attenuates the I/R-induced increased hepatic and/or
mitochondrial oxidative stress and dysfunction
Panels A: HNE adducts (a marker for lipid peroxidation/oxidative stress) are time-
dependently increased following I/R injury peaking at 24 hours. MitoQ/Mito-CP
pretreatment (3 mg/kg i.p.) attenuates these increases.
Panel B: HNE adducts in mitochondrial fraction are increased following I/R 2h and are
attenuated with MitoQ/Mito-CP pretreatment (3 mg/kg i.p.).
Panels C, D: Carbonyl adducts in mitochondrial fraction measured by ELISA or Oxyblot are
increased following I/R 2h and are attenuated with MitoQ/Mito-CP pretreatment (3 mg/kg
i.p.), respectively.
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Panel E: The complex I activity in isolated liver mitochondria is markedly decreased
following I/R 2h, which is attenuated with MitoQ/Mito-CP pretreatment (3 mg/kg i.p.).
*P<0.05 sham control vs. I/R; #P<0.05 I/R vs. corresponding I/R+MitoQ/Mito-CP. For
panels A–C and E n=6–12/group.
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Figure 6. MitoQ and Mito-CP treatment attenuates the I/R-induced increased hepatic
malondialdehyde formation and oxidative DNA damage
Panel A: Malondialdehyde staining (brown; a marker of lipid peroxidation/oxidative stress)
of representative liver sections of sham mice treated with vehicle (sham) or MitoQ/Mito-CP
(antioxidants in sham mice had no effects, not shown), and mice exposed to 1 hour of
ischemia followed by 24 hours of reperfusion (I/R 24h) treated with vehicle or MitoQ/Mito-
CP (3 mg/kg i.p.). 24 hours of I/R triggers marked increase in liver malondialdehyde
formation, which is predominantly localized to endothelial cells, perivascular hepatocytes,
and infiltrating (or attached to the endothelium) inflammatory cells, and these increases are
markedly attenuated by pretreatment with MitoQ/Mito-CP. Minimal staining is seen in the
livers of control mice exposed to sham surgery. Slides are counterstained by nuclear fast red.
Upper row of images depicts 400× magnification, while the lower one 1000× magnification.
A similar histological profile was seen in three to five livers/group.
Panel B: 8-OHdG staining (blue; marker of oxidative DNA damage) of representative liver
sections of sham mice treated with vehicle (sham) or MitoQ/Mito-CP (antioxidants in sham
mice had no effects, not shown) and mice exposed to 1 hour of ischemia followed by 24
hours of reperfusion (I/R 24h) treated with vehicle or MitoQ/Mito-CP. 24 hours of I/R
triggers markedly increased 8-OHdG formation in endothelial cells, perivascular
hepatocytes and infiltrating inflammatory cells, and these changes are attenuated by
pretreatment with MitoQ/Mito-CP. Please note that the necrotic areas are lighter and
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infiltrated by neutrophils showing intense nuclear staining. Minimal nuclear 8-OHdG
staining is seen in the livers of control mice exposed to sham surgery. Upper row of images
depicts 400× magnification, while the lower one 1000× magnification. A similar histological
profile was seen in three to five livers/group.
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Figure 7. MitoQ and Mito-CP treatment attenuates the I/R-induced gp91phox expression
Panels A–C: Real-time PCR and Western blot show significant increase in hepatic
NAD(P)H oxidase isoform NOX2/gp91phox mRNA or protein expression level at 24h of
reperfusion (I/R 24h). Pretreatment with MitoQ/Mito-CP (Panels A and B), but not post-
treatment following 3 hours of reperfusion (Panel C), attenuates the I/R-induced increases.
n=6–14/group. *P<0.05 sham control vs. I/R; #P<0.05 I/R vs. corresponding I/R+MitoQ/
Mito-CP.
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Figure 8. MitoQ and Mito-CP treatment attenuates the I/R-induced increased nitrative stress
Panel A: Protein nitration (3-NT), a marker for nitrative stress, time-dependently increases
following I/R injury peaking at 24 hours. MitoQ/Mito-CP pretreatment (3 mg/kg i.p.)
attenuates this increase. n=8–12/group. *P<0.05 sham control vs. I/R; #P<0.05 I/R vs.
corresponding I/R+MitoQ/Mito-CP.
Panel B: Protein nitration in mitochondria is increased at I/R 2h. MitoQ/Mito-CP
pretreatment (3 mg/kg i.p.) attenuates this increase. n=4–8/group. *P<0.05 sham control vs.
I/R; #P<0.05 I/R vs. corresponding I/R+MitoQ/Mito-CP.
Panel C: 3-Nitrotyrosine staining (brown) of representative liver sections of sham mice
treated with vehicle (sham), MitoQ/Mito-CP and mice exposed to 1 hour of ischemia
followed by 24 hours of reperfusion (I/R 24h) treated with vehicle or MitoQ/Mito-CP.
Images depicts 400× magnification. A similar histological profile was seen in three to five
livers/group.
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Figure 9. MitoQ and Mito-CP treatment attenuates the I/R-induced increased nitrative stress in
hepatocytes, endothelial and inflammatory cells
3-Nitrotyrosine staining of representative liver sections of sham mice treated with vehicle
(sham), MitoQ/Mito-CP and mice exposed to 1 hour of ischemia followed by 24 hours of
reperfusion treated with vehicle (I/R 24h) or MitoQ/Mito-CP. 24 hours of I/R (middle
images) triggers markedly increased 3-NT formation in endothelial cells, perivascular
hepatocytes and infiltrating inflammatory cells, and these changes are attenuated by
pretreatment with MitoQ/Mito-CP. Images depict 1000× magnification. A similar
histological profile was seen in three to five livers/group.
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Figure 10. MitoQ and Mito-CP treatment attenuate the I/R-induced increased acute pro-
inflammatory response
Real-time PCR shows significant increase in hepatic pro-inflammatory cytokine TNF-α,
chemokines MIP-1α and MIP-2 mRNA levels at 2h of reperfusion (I/R 2h), and a gradual
decrease by 24 hours (I/R 24h). Pretreatment with MitoQ/Mito-CP (3 mg/kg i.p.) attenuates
the I/R-induced increased levels of cytokines/chemokines. n=7–12/group. *P<0.05 sham
control vs. I/R; #P<0.05 I/R vs. corresponding I/R+MitoQ/Mito-CP.
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Figure 11. MitoQ and Mito-CP treatment attenuates the I/R-induced increased adhesion
molecule expression and enhanced delayed neutrophil infiltration in the liver
Panel A: Real-time PCR shows significant increase in hepatic adhesion molecule ICAM-1
mRNA level at 2h of reperfusion (I/R 2h), and a gradual decrease by 24 hours (I/R 24h).
Pretreatment with MitoQ/Mito-CP (3 mg/kg i.p.) significantly attenuates the I/R-induced
increased level of adhesion molecule. n=7–12/group. *P<0.05 sham control vs. I/R; #P<0.05
I/R vs. corresponding I/R+MitoQ/Mito-CP.
Panel B: Quantification of MPO activity from the liver extracts shows significant time-
dependent increases associated with I/R (peaking at I/R 24h), which are attenuated by
pretreatment with MitoQ/Mito-CP (3 mg/kg i.p.). n=8–12/group. *P<0.05 sham control vs.
I/R; #P<0.05 I/R vs. corresponding I/R+MitoQ/Mito-CP.
Panel C–D: Myeloperoxidase (MPO) staining (brown) of representative liver sections of
sham mice treated with vehicle (sham) or MitoQ/Mito-CP, and mice exposed to 1 hour of
ischemia followed by 2, 6 or 24 hours of reperfusion treated with vehicle or MitoQ/Mito-
CP. These images reveal increased neutrophils attachment to the endothelium and
accumulation in the vessels at I/R 6h followed by marked infiltration of liver tissue at I/R
24h. Pretreatment with MitoQ/Mito-CP (3 mg/kg i.p.) attenuates the I/R-induced increased
neutrophil infiltration. Slides were counterstained by nuclear fast red. Panel C images depict
200× magnification, while Panel D depicts 400× magnification. A similar histological
profile was seen in three to five livers/group.
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Figure 12. MitoQ and Mito-CP treatment attenuates the I/R-induced increased cell death
Panel A: PARP activity, a marker for cell death (mostly necrotic) increases at 2, 6 and 24 h
of I/R. MitoQ/Mito-CP pretreatment (3 mg/kg i.p.) attenuates these increases.
Panels B and C: DNA fragmentation and caspase 3/7 activity (markers of apoptotic cell
death) increase only from 6 h of I/R peaking at 24 hours. MitoQ/Mito-CP pretreatment (3
mg/kg i.p.) attenuates these increases. n=8–13/group. *P<0.05 sham control vs. I/R; #P<0.05
I/R vs. corresponding I/R+MitoQ/Mito-CP.
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Figure 13. Simplified mechanisms of the interplay of mitochondrial dysfunction and oxidative
stress with inflammatory responses and cell death during hepatic ischemia-reperfusion (I/R)
injury
The metabolic stress during ischemia and initial phase of reperfusion leads to mitochondrial
dysfunction in hepatocytes and sinusoidal endothelial cells, increased mitochondrial reactive
oxygen (e.g. superoxide and hydrogen peroxide) and nitrogen species (e.g. peroxynitrite)
formation (ROS/RNS), Ca2+ accumulation, and activation of various necrotic cell death
pathways by ROS/RNS, such as poly(ADP)-ribose polymerase 1 (PARP-1), which leads to
ATP depletion and early cell necrosis. Superoxide may also readily react with nitric oxide
(NO) during early hepatic reperfusion (the latter can be derived from nitric oxide synthases,
most likely iNOS via a diffusion limited reaction to form a more potent oxidant
peroxynitrite, further impairing mitochondrial and cellular functions and increasing ROS
generation. Hepatic I/R also attenuates endothelial NO synthase activity in sinusoidal
endothelial cells during I/R leading to endothelial dysfunction, favoring sinusoidal
vasoconstriction and secondary ischemic injury. Necrotic hepatocytes and endothelial cells
release various damage-associated molecular patterns (e.g. high mobility group box 1
protein (HMGB1), DNA fragments, and lipid peroxidation products such as hydroxynonenal
(HNE), among others), which activate Kupffer cells (the resident macrophages of the liver)
via several toll like receptors (TLRs) in a nuclear factor kappa B (NFκB)-dependent manner.
The activated Kupffer cells subsequently produce numerous pro-inflammatory cytokines and
chemokines such as tumor necrosis factor α (TNF-α), macrophage inflammatory proteins
(MIP1/2), and additional ROS and nitric oxide (NO) through the increased expression of
ROS generating NAD(P)H oxidase isoform NOX-2 and inducible nitric oxide synthase
(iNOS), further fueling oxidative/nitrative injury and priming/chemotaxis of various
inflammatory cells. The initial oxidant-induced injury also leads to the activation of
endothelial cells which in concert with activated Kupffer cells and certain subtypes of T
lymphocytes orchestrate the acute and delayed pro-inflammatory response leading to
attraction of neutrophils and other inflammatory cells into the damaged tissue upon late
reperfusion. These inflammatory cells further release oxidants and proteolytic enzymes
enhancing intracellular oxidative/nitrative stress and mitochondrial dysfunction in
hepatocytes, thereby promoting apoptotic and/or necrotic forms of cell demise.
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